Pages that link to "Q43700608"

The following pages link to Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia (Q43700608):

Displaying 49 items.

• The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy (Q26744087) (← links)
• Antigen-specific immunotherapy of cervical and ovarian cancer (Q27488697) (← links)
• CRPV genomes with synonymous codon optimizations in the CRPV E7 gene show phenotypic differences in growth and altered immunity upon E7 vaccination (Q28473368) (← links)
• Immunotherapy for cervical cancer: Research status and clinical potential (Q34033763) (← links)
• Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responses (Q34045548) (← links)
• A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers (Q34121681) (← links)
• Recombinant lipidated HPV E7 induces a Th-1-biased immune response and protective immunity against cervical cancer in a mouse model (Q34345467) (← links)
• Vaccines: past, present and future (Q34409178) (← links)
• Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses (Q35049821) (← links)
• Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial (Q35055665) (← links)
• A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer (Q35169110) (← links)
• Therapeutic Vaccine Strategies against Human Papillomavirus (Q35826752) (← links)
• Natural killer cells: role in local tumor growth and metastasis (Q35905953) (← links)
• Progress in the development of a cervical cancer vaccine. (Q35919119) (← links)
• Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries: a meta-analysis (Q36237280) (← links)
• Immunotherapy for gynaecological malignancies. (Q36239661) (← links)
• Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy (Q36373370) (← links)
• Gene therapy in gynecological cancer (Q36532089) (← links)
• Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers (Q36652548) (← links)
• Human papillomavirus vaccines for the treatment of cervical cancer (Q36690278) (← links)
• Human papillomavirus therapeutic vaccines in head and neck tumors (Q36817148) (← links)
• HPV Vaccines: today and in the Future (Q36976268) (← links)
• Prevention and Inhibition of TC-1 Cell Growth in Tumor Bearing Mice by HPV16 E7 Protein in Fusion with Shiga Toxin B-Subunit from shigella dysenteriae (Q37017281) (← links)
• Protective immunity with an E1 multivalent epitope DNA vaccine against cottontail rabbit papillomavirus (CRPV) infection in an HLA-A2.1 transgenic rabbit model (Q37208345) (← links)
• Therapeutic vaccination of rabbits with a ubiquitin-fused papillomavirus E1, E2, E6 and E7 DNA vaccine (Q37240133) (← links)
• Therapeutic vaccines against human papillomavirus and cervical cancer (Q37418916) (← links)
• Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies (Q37494787) (← links)
• Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis (Q37579334) (← links)
• HPV as a model for the development of prophylactic and therapeutic cancer vaccines. (Q37581762) (← links)
• Prevention and Treatment of Papillomavirus-Related Cancers Through Immunization (Q37821922) (← links)
• Human papillomavirus as a target for management, prevention and therapy (Q38018120) (← links)
• Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer. (Q38089937) (← links)
• Cell-mediated immune response: a clinical review of the therapeutic potential of human papillomavirus vaccination (Q38242083) (← links)
• The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL /6 mouse model (Q39474019) (← links)
• Immunization of protein HPV16 E7 in fusion with mouse HSP70 inhibits the growth of TC-1 cells in tumor bearing mice (Q39514442) (← links)
• The epidemiological contribution to the preparation of field trials for HIV and STI vaccines: objectives and methods of feasibility studies. (Q40451304) (← links)
• Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic (Q40702089) (← links)
• Potato virus X coat protein fusion to human papillomavirus 16 E7 oncoprotein enhance antigen stability and accumulation in tobacco chloroplast. (Q45383063) (← links)
• Proceedings From the First Asia-Oceania Research Organisation on Genital Infections and Neoplasia (AOGIN) Meeting (Q45812304) (← links)
• Elimination of high-risk human papillomavirus type HPV16 infection by 'Praneem' polyherbal tablet in women with early cervical intraepithelial lesions. (Q45969444) (← links)
• A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia. (Q46564278) (← links)
• Targeted immunotherapy of high-grade cervical intra-epithelial neoplasia: Expectations from clinical trials (Q50052586) (← links)
• Translational fusion and redirection to thylakoid lumen as strategies to enhance accumulation of human papillomavirus E7 antigen in tobacco chloroplasts (Q51070857) (← links)
• [Prophylactic and therapeutic vaccines against human papilloma virus]. (Q52903256) (← links)
• Murine HPV16 E7-expressing transgenic skin effectively emulates the cellular and molecular features of human high-grade squamous intraepithelial lesions. (Q54937688) (← links)
• Therapeutic human papillomavirus vaccines: current clinical trials and future directions (Q56937332) (← links)
• Emerging human papillomavirus vaccines (Q56967486) (← links)
• Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus (Q59329445) (← links)
• Current status of therapeutic HPV vaccines (Q92213753) (← links)